Success with treat-to-target therapy in rheumatoid arthritis lasts up to two decades: Study
Netherlands: A recent article published in the Rheumatology journal has reported long-term clinical outcomes in early rheumatoid arthritis (RA) that was treated to target in the IMPROVED and the BeSt studies. The study that followed participants in two of the first clinical trials to test the strategy revealed that success with “treat-to-target” therapy for early-stage […]